ICP-332 in Subjects With Non-segmental Vitiligo

Clinical trial NCT07047612 · RECRUITING

Trial details

NCT number: NCT07047612
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Non Segmental Vitiligo

Start date: 2025-05-09
Primary completion: 2029-04-01
Enrollment: 603

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.